AUCTORES
Globalize your Research
Case Report | DOI: https://doi.org/10.31579/2637-8876/037
1 Professor of neurology, Isfahan Neurosciences Research Center, neurology department, Isfahan University of Medical Sciences, Isfahan, Iran
2 Resident of eurology, Isfahan Neurosciences Research Center, neurology department, Isfahan University of Medical Sciences, Isfahan, Iran
*Corresponding Author: Mohmmad Amin Najafi, Alzahra hospital, neurology department, Isfahan University of Medical Sciences, Sofeh Street, Isfahan, Iran.
Citation: Jafar Mehvari, Mohsen Kheradmand, Mohammad Amin Najafi, Elham Azimi. (2022) Report of two Cases of Acute Ischemic Stroke after ChAdOx1-S (Oxford–AstraZeneca) Covid-19 Vaccine. J. Immunology and Inflammation Diseases Therapy. 5(2); Doi:10.31579/2637-8876/037
Copyright: © 2022 Mohmmad Amin Najafi. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 07 March 2022 | Accepted: 19 April 2022 | Published: 27 April 2022
Keywords: stroke; astrazeneca vaccine; embolic stroke
Safety concerns regarding an elevated risk of thrombosis in vaccinated individuals by the AstraZeneca COVID-19 vaccine has been created. This case report describes two cases of acute ischemic stroke within 48 hour of vaccination by AstraZeneca COVID-19 vaccine in MAY 2021, with up to 7 days follow up. Both patients have proven risk factors for cardioembolic events; heart failure and premature atrial contractions in patient 1, atrial fibrillation and mitral valve stenosis in patient 2. We suggest that using AstraZeneca vaccine in patients with cardioembolic risk factors requires more caution.
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1]. The risk of both venous and arterial thromboembolism is increased in COVID-19 infection [2]. Effective vaccination is the only way for the radical control of COVID- 19. Several vaccines have been licensed and are currently being used in Iran to combat the COVID-19 pandemic. COVID-19 vaccine from AstraZeneca has been recently used in Iran for over 80s individuals. Safety concerns regarding an elevated risk of thrombosis in vaccinated individuals are created according to reports of cases of thrombosis among individuals vaccinated by the AstraZeneca COVID-19 vaccine in the European Union [3]. However, The European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee reported that the vaccine is safe, effective and the benefits outweighed the risks [4]. This study reports 2 cases of acute ischemic stroke following AstraZeneca COVID-19 vaccination within 48 hours.
An 88-year-old man presented to the emergency room due to acute-onset dysarthria after morning wake up. The patient's past medical history was significant for hypertension and heart failure which he was receiving Furosemide, Spironolactone, and Nitrocontin. The patient was vaccinated for COVID-19 (Vaccine AstraZeneca) 36 hours before the onset of symptoms. Vital signs were within normal limits. Neurological examination was positive for dysarthria and minor left facial paresis. The motor and sensation were intact in the limbs. No other focal neurologic deficit was seen in neurological examination. National Institutes of Health Stroke Scale (NIHSS) score was 2. Laboratory studies including complete blood count (CBC) and complete metabolic panel (CMP) were within normal limits. Computed tomography (CT) scan of the head showed no acute intracranial abnormality. Magnetic resonance imaging (MRI) was subsequently obtained and revealed right frontal cortical infarction in territory of the superior division of middle cerebral artery (MCA) (figure 1).
Magnetic resonance venography (MRV) was normal. Dual antiplatelet therapy; clopidogrel 75 mg daily and aspirin 80 mg daily; and high-intensity statin was started. EKG showed premature atrial contractions. Echocardiography reported ejection fraction of 20%. Carotid/vertebral duplex and Transcranial Doppler (TCD) reported no significant stenosis. According to mentioned findings, with the diagnosis of embolic stroke, Aspirin and Clopidogrel were discontinued, and Warfarin was started. After international normalized ratio (INR) reached above 2, the patient was discharged. The patient was re-examined after 7 days. The INR was remained in therapeutic range [2,3] NIHSS score was reduced to 1 and no other thromboembolic events was happened.
Case 2
An 83-year-old man presented to the emergency room due to acute-onset dysarthria, right-sided facial droop, and right-sided hemiparesis since 6 hours ago. The patient's past medical history was significant for hypertension and chronic kidney disease which he was receiving metoprolol, losartan, furosemide, and allopurinol. The patient was vaccinated for COVID-19 (Vaccine AstraZeneca) 24 hours before the onset of symptoms. Vital signs were within normal limits. Neurological examination was positive for dysarthria, right facial paresis, right-sided hemiplegia affecting the upper and lower extremities and right–sided hemisensory loss. National Institutes of Health Stroke Scale (NIHSS) score was 10. Laboratory studies including CBC and CMP were within normal limits. CT scan of the head showed acute infarction in the left frontal region. MRI was subsequently obtained and revealed left frontal infarction with hemorrhagic transformation in territory of the superior division of MCA (figure 2).
MRV was normal. Aspirin 80 mg daily as well as high-intensity statin was started. EKG showed atrial fibrillation. Echocardiography revealed an ejection fraction of 55%, moderate mitral stenosis and moderate mitral regurgitation. Carotid/vertebral duplex and TCD showed no significant stenosis. According to mentioned findings, with the diagnosis of embolic stroke, aspirin was discontinued, and Warfarin was started. After INR reached above 2, the patient was discharged. The patient was re-examined after 7 days. The INR was remained in therapeutic range [2.6], NIHSS score was remained 10 and no other thromboembolic events was happened.
Chimpanzee adenovirus encoding the SARS-CoV-2 spike glycoprotein (ChAdOx1-S)
known as Oxford–AstraZeneca vaccine is one of the several vaccines produced to combat COVID-19 infection [5]. EudraVigilance (EV) database [6] reported 54,571 adverse reaction (AR) for ChAdOx1-S. Most frequent ARs were mild to moderate in severity, including injection site tenderness, injection site pain, fatigue, headache, malaise, myalgia, and pyrexia [5].
However, severe side effects have also been reported to a limited extent, which in some cases has caused death [4,5]. One of these severe complications was an incidence of thromboembolic events [3]. According to EMA, among approximately 5 million Oxford–AstraZeneca vaccine recipients, 28 cases of thromboembolic events had been reported by March 10, 2021 [4]. These reports mainly included pulmonary embolism, cerebral venous sinus thrombosis, deep vein thrombosis, thrombophlebitis, pelvic venous thrombosis and one carotid artery thrombosis [4]. More than half of the reports were people over 85 years old. Paul Ehrlich Institute (PEI) had reported 13 cases of sinus or cerebral vein thrombosis among 1.6 million AstraZeneca recipients [3]. The Interval time between vaccination and thromboses was 4 to 16 days in 12 women, and one managed 20 to 63 years [3]. The patients also had a triad of thromboembolic events; thrombocytopenia and anti-PF4 antibodies appear to be characteristic of the Heparin-induced-thrombocytopenia (HIT), which was also reported in other reports [7-12]. The vaccination is likely to induce the formation of antibodies against platelet antigens. [3] These antibodies cause platelet activation via the Fc receptor. The same thing was happening in heparin-induced thrombocytopenia (HIT) [3]. No other mechanism has been suggested to explain these thrombotic events so far.
About 70% of patients with HIT develop thrombosis, most often vein thrombosis, but arterial thrombosis has also been reported [13]. Reports have been mostly related to venous thrombosis [7-12], and only a few cases of arterial thrombosis have been reported [7]. In this article, we describe two patients who experience arterial ischemic stroke after receiving the ChAdOx1-S vaccine. The median age was 85 years old, and both of them were male who is contradicting other articles that reports of priority of female compared to males.
Both patients have proven cardioembolic risk factors for cardiovascular [14]. Patient 1 )reduction in EF, EF=20%) and patient 2 (mitral stenosis and atrial fibrillation rhythm) were prone to cardioembolic events. By so far, they have no history of stroke or transient ischemic attack before vaccination.
We believe that HIT was not a mechanism implicated in arterial embolism or arterial thrombosis in our patients.There are reasons to support this claim. In both patients, there was no progressive platelet fall or platelet drop of more than 50%. Also, the clot formed on the first and second day after vaccination, which is contrary to the classic HIT diagnostic criteria [13]. According to the 4T criteria of determining HIT possibility [15], our patients are categorized as a low probability for HIT. Therefore, platelets Antibodies do not evaluate.
Regardless of HIT mechanism, it is unclear whether there is a specific link between the Oxford–AstraZeneca vaccine and development of thromboembolic events or its just co-accidental happening. According to presence of cardioembolic risk factors in both of our cases, it is suggested to use AstraZeneca vaccine in patients with cardioembolic risk factors with more cautions. However, further studies will be necessary to evaluate this relationship.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
